We thank 50+ health systems, representing 1,200+ hospitals across the US, for joining Civica Rx to help ensure quality medicines are accessible and affordable to everyone. These include:

.

Recent News

Civica Update: Civica Rx Partners on COVID-19 Response and “End-to-End” U.S. Based Generic Drug Manufacturing

  Civica Rx  is part of a new U.S. Government-funded partnership that was announced today to produce essential generic medicines and their ingredients at one location in the United States. Teams within the Department of Health and Human Services (HHS) are working with a team of private industry partners to expand generic pharmaceutical manufacturing...

Recent Recognition

Fast Company lists Civica as one of The World's 50 Most Innovative Companies for manufacturing generic drugs at lower prices to combat shortages and rising healthcare costs. Modern Healthcare names Martin VanTrieste, President and CEO of Civica Rx, as one of The 100 Most Influential People in Healthcare. “This recognition is a reflection of everything the...

Why Civica?

Over the past two decades, shortages of generic, injectable drugs critical to the lifesaving work of hospitals in the United States have become commonplace. These drug shortages are so ubiquitous that hospitals and health care systems now maintain permanent drug shortage response teams that seek alternatives to unavailable drugs.

As a result, time that hospital pharmacists, technicians, nurses and others would prefer to spend caring for patients is spent ensuring that the patients who most need short-supply drugs get whatever supply is available.

Civica was created to reduce and prevent drug shortages and the price spikes that can accompany them. Its mission is to make quality generic medicines accessible and affordable to everyone.